Johnson,And,Johnson,Sign,,Logo,At,An,American,Multinational,Corporation Credit: Michael Vi/Shutterstock.com

A New Jersey district court has denied a motion to dismiss a suit filed by Johnson & Johnson that alleges that the company has paid significantly more in co-pay assistance than it otherwise would have as a result of defendant SaveOnSP's services.

According to the opinion, Johnson & Johnson Health Care Systems, a J&J subsidiary, alleged that SaveOnSP created a plan to deplete the Janssen CarePath program. The CarePath program provides financial assistance to patients for out-of-pocket costs for 44 medications manufactured by J&J. The medications treat a variety of cancers, pulmonary arterial hypertension, and autoimmune disorders and many have no generic substitutes available.